Based on the below from the AR it looks like they are thinking ahead in relation to NNZ-2591 partnership. Its a bullish statement. I wonder if they are in discussions with any parties at the moment as i recall Jon did mention they had interest.
NNZ-2591 has the potential to generate larger value for shareholders than trofinetide. We are now carefully evaluating all options to maximize this value, preparing actively for Phase 3 studies while remaining receptive to partnering alternatives.
- Forums
- ASX - By Stock
- NEU
- Ann: 2022 Annual Report to shareholders
NEU
neuren pharmaceuticals limited
Add to My Watchlist
2.06%
!
$12.83

Ann: 2022 Annual Report to shareholders, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$12.83 |
Change
-0.270(2.06%) |
Mkt cap ! $1.607B |
Open | High | Low | Value | Volume |
$13.20 | $13.36 | $12.83 | $2.850M | 217.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 384 | $12.82 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.84 | 359 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 559 | 12.870 |
5 | 951 | 12.860 |
15 | 2157 | 12.850 |
13 | 1515 | 12.840 |
8 | 1421 | 12.830 |
Price($) | Vol. | No. |
---|---|---|
12.880 | 374 | 7 |
12.890 | 1662 | 9 |
12.900 | 1029 | 16 |
12.910 | 1447 | 13 |
12.920 | 1303 | 9 |
Last trade - 13.43pm 16/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |